晚期截瘫患者抑郁症评定对比分析

目的:采用抑郁自评量表(self-rating depression scale,SDS)和汉密尔顿抑郁量表(Hamilton depression rating scale fordepression,HAMD)评价表探讨截瘫患者抑郁症发生率及其影响因素,并进行对比分析,为截瘫患者的全面康复治疗提供依据。方法:SDS和HAMD以问卷调查方式对56例晚期截瘫患者进行抑郁症调查,并分析抑郁症发生与患者性别、年龄、疼痛、病程、治疗费用来源、家人及社会关怀、文化程度、个人收入的关系。对照组随机选择同期住院其他骨科疾病患者51例作为其他疾病组,正常对照组为门诊健康体检者35例。结果:截瘫患者SDS评价中抑郁症发生率为82.1%(46/56),中重度发生率为46.4%(26/56),HAMD评价体系中抑郁症发生率为89.3%(50/56),中重度发生率为51.8%(29/56),均显著高于其他疾病组和正常对照组。中重度抑郁发生与病程、治疗费用来源、家人及社会关怀显著相关,HAMD评价中还与个人收入相关。结论:截瘫患者中重度抑郁症发病率较高,SDS和HAMD评价体系结合应用能较完善反应截瘫患者的心理变化及社会相关因素。良好的医疗措施、家庭社会关怀及经济支持可以显著减轻截瘫后抑郁症状的发生。

Analysis of incidence of depression in patients suffered from paraplegia evaluated with SDS and HAMD

Objective: To investigate the incidence of depression in patients suffered from paraplegia,analyze the influential factors,and find more effective rehabilitation method.Methods: Self-rating depression scale(SDS) and Hamilton rating scale for depression(HAMD) were used to evaluate the incidence of depression in 56 patients suffered from paraplegia and the influential factors of depression,such as sex,age,pain,course,education,treatment expense and income were analyzed.51 patients suffering from other diseases and 35 healthy people were selected as the disease group and healthy group,respectively.Results:Based on SDS evaluation,the incidence of depression in paraplegia group was 82.1%(46/56) and the incidence of moderate and severe depression was 46.4%(26/56).Based on HAMD evaluation,the incidence of depression in paraplegia group was 89.3%(50/56) and the incidence of moderate and severe depression was 51.8%(29/56).The incidence of depression in paraplegia group was very higher than that in other two groups(P<0.01).The incidence of moderate and severe depression was related to course,treatment expense,family and society concern.Based on HAMD evaluation,personal income was an influential factor,too.Conclusion:The incidence of moderate and severe depression was very high among paraplegia patients.Good treatment,family and society concern,and economic support can decrease effectively the incidence of depression among paraplegia patients.